Opinion/decision on a Paediatric investigation plan (PIP): Ebglyss, Lebrikizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0382/2024
Opinion/decision on a Paediatric investigation plan (PIP): Ebglyss, Lebrikizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0382/2024
